Since Sherlock Biosciences was founded in 2018, it has participated in 5 rounds of funding. In total Sherlock Biosciences has raised $142.8M. Sherlock Biosciences' last funding round was on Mar 2022 for a total of $80.0M.
Sherlock Biosciences has 9 investors, including Novalis LifeSciences, Illumina Ventures and Catalio Capital Management. The latest investment occurred in Mar 2022.